Ocuphire Pharma (NASDAQ:OCUP) reported quarterly losses of $(0.22) per share. This is a 12 percent increase over losses of $(0.25) per share from the same period last year.
DA Davidson Initiates Coverage On Manhattan Associates with Neutral Rating, Announces Price Target of $145
DA Davidson analyst Gil Luria initiates coverage on Manhattan Associates (NASDAQ:MANH) with a Neutral rating and announces Price Target of $145.